By activating GLP-1 receptors, retatrutide helps stimulate insulin secretion in a glucose-dependent manner, reduces appetite, and slows gastric emptying contributing to improved blood glucose control and reduced caloric intake
Most Common Reaction Temporary pain, redness, tenderness, or swelling at the injection site Other Reported Symptoms Headache, flushing, dizziness, itching, sleepiness, or restlessness Administration Typically administered subcutaneously when prescribed that way Medical Supervision Dosing and treatment duration should be determined by a qualified provider Not Every Symptom Has the Same Meaning A small area of temporary redness after an injection is different from redness that spreads, becomes increasingly painful, feels warm, produces drainage, or occurs with fever
Sensitive skin caution: If you have sensitive skin or fragrance allergies, no worries
Springer Science+Business Media
Growth pattern is disordered
This is the case when palpitations are coming from anxiety